Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E

Abstract Botulinum neurotoxins (BoNTs) represent a family of bacterial toxins responsible for neuroparalytic disease ‘botulism’ in human and animals. Their potential use as biological weapon led to their classification in category ‘A’ biowarfare agent by Centers for Disease Control and Prevention (C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Priyanka Sonkar, Vinita Chauhan, Ritika Chauhan, Nandita Saxena, Ram Kumar Dhaked
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a77fcbcca8e64d5d85a856dbbf4c6918
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a77fcbcca8e64d5d85a856dbbf4c6918
record_format dspace
spelling oai:doaj.org-article:a77fcbcca8e64d5d85a856dbbf4c69182021-12-02T16:46:33ZCharacterization of immune response induced against catalytic domain of botulinum neurotoxin type E10.1038/s41598-020-70929-82045-2322https://doaj.org/article/a77fcbcca8e64d5d85a856dbbf4c69182020-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-70929-8https://doaj.org/toc/2045-2322Abstract Botulinum neurotoxins (BoNTs) represent a family of bacterial toxins responsible for neuroparalytic disease ‘botulism’ in human and animals. Their potential use as biological weapon led to their classification in category ‘A’ biowarfare agent by Centers for Disease Control and Prevention (CDC), USA. In present study, gene encoding full length catalytic domain of BoNT/E-LC was cloned, expressed and protein was purified using Ni–NTA chromatography. Humoral immune response was confirmed by Ig isotyping and cell-mediated immunity by cytokine profiling and intracellular staining for enumeration of IFN-γ secreting CD4+ and CD8+ T cells. Increased antibody titer with the predominance of IgG subtype was observed. An interaction between antibodies produced against rBoNT/E-LC was established that showed the specificity against BoNT/E in SPR assay. Animal protection with rBoNT/E-LC was conferred through both humoral and cellular immune responses. These findings were supported by cytokine profiling and flow cytometric analysis. Splenocytes stimulated with rBoNT/E-LC showed a 3.27 and 2.8 times increase in the IFN-γ secreting CD4+ and CD8+ T cells, respectively; in immunized group (P < 0.05). Protection against BoNT/E challenge tended to relate with increase in the percentage of rBoNT/E-LC specific IL-2 in the splenocytes supernatant (P = 0.034) and with IFN-γ-producing CD4+ T cell responses (P = 0.045). We have immunologically evaluated catalytically active rBoNT/E-LC. Our results provide valuable investigational report for immunoprophylactic role of catalytic domain of BoNT/E.Priyanka SonkarVinita ChauhanRitika ChauhanNandita SaxenaRam Kumar DhakedNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Priyanka Sonkar
Vinita Chauhan
Ritika Chauhan
Nandita Saxena
Ram Kumar Dhaked
Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E
description Abstract Botulinum neurotoxins (BoNTs) represent a family of bacterial toxins responsible for neuroparalytic disease ‘botulism’ in human and animals. Their potential use as biological weapon led to their classification in category ‘A’ biowarfare agent by Centers for Disease Control and Prevention (CDC), USA. In present study, gene encoding full length catalytic domain of BoNT/E-LC was cloned, expressed and protein was purified using Ni–NTA chromatography. Humoral immune response was confirmed by Ig isotyping and cell-mediated immunity by cytokine profiling and intracellular staining for enumeration of IFN-γ secreting CD4+ and CD8+ T cells. Increased antibody titer with the predominance of IgG subtype was observed. An interaction between antibodies produced against rBoNT/E-LC was established that showed the specificity against BoNT/E in SPR assay. Animal protection with rBoNT/E-LC was conferred through both humoral and cellular immune responses. These findings were supported by cytokine profiling and flow cytometric analysis. Splenocytes stimulated with rBoNT/E-LC showed a 3.27 and 2.8 times increase in the IFN-γ secreting CD4+ and CD8+ T cells, respectively; in immunized group (P < 0.05). Protection against BoNT/E challenge tended to relate with increase in the percentage of rBoNT/E-LC specific IL-2 in the splenocytes supernatant (P = 0.034) and with IFN-γ-producing CD4+ T cell responses (P = 0.045). We have immunologically evaluated catalytically active rBoNT/E-LC. Our results provide valuable investigational report for immunoprophylactic role of catalytic domain of BoNT/E.
format article
author Priyanka Sonkar
Vinita Chauhan
Ritika Chauhan
Nandita Saxena
Ram Kumar Dhaked
author_facet Priyanka Sonkar
Vinita Chauhan
Ritika Chauhan
Nandita Saxena
Ram Kumar Dhaked
author_sort Priyanka Sonkar
title Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E
title_short Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E
title_full Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E
title_fullStr Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E
title_full_unstemmed Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E
title_sort characterization of immune response induced against catalytic domain of botulinum neurotoxin type e
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/a77fcbcca8e64d5d85a856dbbf4c6918
work_keys_str_mv AT priyankasonkar characterizationofimmuneresponseinducedagainstcatalyticdomainofbotulinumneurotoxintypee
AT vinitachauhan characterizationofimmuneresponseinducedagainstcatalyticdomainofbotulinumneurotoxintypee
AT ritikachauhan characterizationofimmuneresponseinducedagainstcatalyticdomainofbotulinumneurotoxintypee
AT nanditasaxena characterizationofimmuneresponseinducedagainstcatalyticdomainofbotulinumneurotoxintypee
AT ramkumardhaked characterizationofimmuneresponseinducedagainstcatalyticdomainofbotulinumneurotoxintypee
_version_ 1718383414717972480